Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas
Abstract Background Neck dissection is standard in surgical management of oral squamous cell carcinomas (oscc). However, the immunologic link between primary tumor and lymph nodes is insufficiently understood. Galectin 3 (Gal3) promotes M2 polarization of macrophages and contributes to immunosuppres...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4726-6 |
id |
doaj-cf1b70f260f74382809c3624383aeab0 |
---|---|
record_format |
Article |
spelling |
doaj-cf1b70f260f74382809c3624383aeab02020-11-24T21:24:39ZengBMCBMC Cancer1471-24072018-08-0118111010.1186/s12885-018-4726-6Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomasFalk Wehrhan0Maike Büttner-Herold1Luitpold Distel2Jutta Ries3Patrick Moebius4Raimund Preidl5Carol I. Geppert6Friedrich W. Neukam7Marco Kesting8Manuel Weber9Department of Oral and Maxillofacial Surgery, Friedrich-Alexander University Erlangen-NürnbergDepartment of Nephropathology, Institute of Pathology, Friedrich-Alexander University Erlangen-NürnbergDepartment of Radiation Oncology, Friedrich-Alexander University Erlangen-NürnbergDepartment of Oral and Maxillofacial Surgery, Friedrich-Alexander University Erlangen-NürnbergDepartment of Oral and Maxillofacial Surgery, Friedrich-Alexander University Erlangen-NürnbergDepartment of Oral and Maxillofacial Surgery, Friedrich-Alexander University Erlangen-NürnbergInstitute of Pathology, Friedrich-Alexander University Erlangen-NürnbergDepartment of Oral and Maxillofacial Surgery, Friedrich-Alexander University Erlangen-NürnbergDepartment of Oral and Maxillofacial Surgery, Friedrich-Alexander University Erlangen-NürnbergDepartment of Oral and Maxillofacial Surgery, Friedrich-Alexander University Erlangen-NürnbergAbstract Background Neck dissection is standard in surgical management of oral squamous cell carcinomas (oscc). However, the immunologic link between primary tumor and lymph nodes is insufficiently understood. Galectin 3 (Gal3) promotes M2 polarization of macrophages and contributes to immunosuppression. The current study analyzes the association between Gal3 expression in regional lymph nodes of oscc with histomorphologic parameters (T-, N-, L- Pn-stage, grading) of the primary tumor. Additionally, Gal3 expression is correlated with markers of macrophage polarization (M1 vs. M2). Methods Preoperative diagnostic biopsies (n = 26), tumor resection specimens (n = 34), tumor-free lymph nodes (n = 28) and lymph node metastases (n = 10) of T1/T2 oscc patients were immunohistochemically analyzed for Gal3 and macrophage marker (CD68, CD11c, CD163 and MRC1) expression. The number of positive cells and the expression ratios were quantitatively assessed. Results High Gal3 expression in tumor-free regional lymph nodes was significantly (p < 0.05) associated with increased tumor size. The epithelial compartment of lymph node metastases showed a significantly (p < 0.05) increased Gal3 expression compared to biopsies and tumor resection specimens. Cell density of M2 macrophages was significantly (p < 0.05) and positively correlated with the number of Gal3 expressing cells in lymph nodes and tumor specimens. Conclusion Gal3 expression in regional lymph nodes might be associated with oscc progression. The increased Gal3 expression in regional lymph nodes of larger tumors underlines the need of immunomodulatory treatment concepts in early-stage oscc. Blocking of Gal3 might be a therapeutic option in oral cancer.http://link.springer.com/article/10.1186/s12885-018-4726-6Oral squamous cell carcinomaOsccLymph nodeMetastasisOral cancerGalectin 3 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Falk Wehrhan Maike Büttner-Herold Luitpold Distel Jutta Ries Patrick Moebius Raimund Preidl Carol I. Geppert Friedrich W. Neukam Marco Kesting Manuel Weber |
spellingShingle |
Falk Wehrhan Maike Büttner-Herold Luitpold Distel Jutta Ries Patrick Moebius Raimund Preidl Carol I. Geppert Friedrich W. Neukam Marco Kesting Manuel Weber Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas BMC Cancer Oral squamous cell carcinoma Oscc Lymph node Metastasis Oral cancer Galectin 3 |
author_facet |
Falk Wehrhan Maike Büttner-Herold Luitpold Distel Jutta Ries Patrick Moebius Raimund Preidl Carol I. Geppert Friedrich W. Neukam Marco Kesting Manuel Weber |
author_sort |
Falk Wehrhan |
title |
Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas |
title_short |
Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas |
title_full |
Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas |
title_fullStr |
Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas |
title_full_unstemmed |
Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas |
title_sort |
galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2018-08-01 |
description |
Abstract Background Neck dissection is standard in surgical management of oral squamous cell carcinomas (oscc). However, the immunologic link between primary tumor and lymph nodes is insufficiently understood. Galectin 3 (Gal3) promotes M2 polarization of macrophages and contributes to immunosuppression. The current study analyzes the association between Gal3 expression in regional lymph nodes of oscc with histomorphologic parameters (T-, N-, L- Pn-stage, grading) of the primary tumor. Additionally, Gal3 expression is correlated with markers of macrophage polarization (M1 vs. M2). Methods Preoperative diagnostic biopsies (n = 26), tumor resection specimens (n = 34), tumor-free lymph nodes (n = 28) and lymph node metastases (n = 10) of T1/T2 oscc patients were immunohistochemically analyzed for Gal3 and macrophage marker (CD68, CD11c, CD163 and MRC1) expression. The number of positive cells and the expression ratios were quantitatively assessed. Results High Gal3 expression in tumor-free regional lymph nodes was significantly (p < 0.05) associated with increased tumor size. The epithelial compartment of lymph node metastases showed a significantly (p < 0.05) increased Gal3 expression compared to biopsies and tumor resection specimens. Cell density of M2 macrophages was significantly (p < 0.05) and positively correlated with the number of Gal3 expressing cells in lymph nodes and tumor specimens. Conclusion Gal3 expression in regional lymph nodes might be associated with oscc progression. The increased Gal3 expression in regional lymph nodes of larger tumors underlines the need of immunomodulatory treatment concepts in early-stage oscc. Blocking of Gal3 might be a therapeutic option in oral cancer. |
topic |
Oral squamous cell carcinoma Oscc Lymph node Metastasis Oral cancer Galectin 3 |
url |
http://link.springer.com/article/10.1186/s12885-018-4726-6 |
work_keys_str_mv |
AT falkwehrhan galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas AT maikebuttnerherold galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas AT luitpolddistel galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas AT juttaries galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas AT patrickmoebius galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas AT raimundpreidl galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas AT caroligeppert galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas AT friedrichwneukam galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas AT marcokesting galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas AT manuelweber galectin3expressioninregionallymphnodesandlymphnodemetastasesoforalsquamouscellcarcinomas |
_version_ |
1725986984431714304 |